RESCON Summit 2025 is a strategic forum for professionals developing inhaled or intranasally delivery drug products. Held on November 5–6, 2025, in San Francisco, the summit gathers experts from the pharmaceutical, biotechnology, and medical device sectors to discuss current trends, emerging technologies, and development strategies in inhaled therapeutics. The 2025 program will cover recent advances across the full development spectrum — including small molecules, lipid nanoparticles (LNPs), smart inhaler systems, AI-assisted design, and digital health integration. With dedicated focus on aspects such as commercial feasibility, regulatory considerations, and collaborative approaches, RESCON Summit 2025 provides a platform for informed discussion and exchange in this evolving field.